Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology
Launched by ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY · May 5, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how eye examinations, combined with advanced technology, can help identify lung diseases early. Researchers want to see if results from eye tests can provide new ways to screen for pulmonary diseases, which affect breathing and lung function. By using big data and artificial intelligence, the study aims to improve the way doctors diagnose and understand these conditions.
To participate, you need to be at least 18 years old, or younger with a guardian's consent, and have a respiratory-related disease or be willing to take part in the study. You should also be able to undergo both eye and lung examinations and agree to follow-up visits. If you have serious eye issues or other major health problems that could affect your ability to participate, you may not be eligible. If you join the study, you'll have the chance to help researchers find better ways to screen for and understand lung diseases, which could make a difference for many patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Those aged ≥18 years; or those aged \<18 years who can cooperate with the relevant examination and are accompanied and informed by a guardian;
- • People with respiratory-related diseases who were to undergo pulmonary examination, or those who volunteered to participate in the trial through publicity recruitment;
- • expected survival time of 3 months or more;
- • Those with no previous serious underlying disease and no history of serious eye disease;
- • Those who can cooperate with ophthalmologic and pulmonary-related examinations and have regular follow-up examinations;
- • Those who gave informed consent to the study prior to the trial and voluntarily signed the informed consent form;
- • Other conditions that can be included in the study as judged by the investigator.
- Exclusion Criteria:
- • Patients who are unable to complete ophthalmology or pulmonary-related examinations and regular follow-ups due to serious diseases, trauma or surgery (serious ophthalmology diseases such as extremely poor vision that cannot be fixed, ocular atrophy, severe refractive interstitial clouding that prevents fundus photography, etc.);
- • People with poor compliance due to various reasons such as alcohol or drug dependence, or mental disorders;
- • Those without informed consent;
- • Other conditions judged by the investigator to be unsuitable for participation in the trial.
About Zhongshan Ophthalmic Center, Sun Yat Sen University
The Zhongshan Ophthalmic Center, affiliated with Sun Yat-sen University, is a leading institution in ophthalmic research and clinical care in China. Renowned for its commitment to advancing the field of ophthalmology, the center specializes in innovative treatments and technologies for various eye conditions. With a strong emphasis on clinical trials, the center aims to enhance patient outcomes through rigorous scientific investigation and collaboration with global research networks. Its multidisciplinary team of experts is dedicated to fostering cutting-edge research that translates into effective therapeutic strategies for vision preservation and restoration.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Guangzhou, Guangdong, China
Shenzhen, Guangdong, China
Guangzhou, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported